Goeltz II Robert C. 4
4 · Arcus Biosciences, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-02$20.00/sh−2,004$40,080→ 51,831 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.